gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Peripheral Arterial Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, CG; Kang, JW; Kim, JK; Ko, GY; Kwon, TW; Lim, TH | 1 |
| Arnaiz, J; Attenberger, UI; Haneder, S; Loewe, C; Michaely, HJ; Schoenberg, SO | 1 |
2 trial(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Peripheral Arterial Disease
| Article | Year |
|---|---|
Evaluation of contrast-enhanced magnetic resonance angiography (MRA) using Gd-DOTA compared with time-of-flight MRA in the diagnosis of clinically significant non-coronary arterial disease.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Coronary Artery Disease; Female; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Angiography; Male; Middle Aged; Organometallic Compounds; Peripheral Arterial Disease; Reproducibility of Results; Sensitivity and Specificity | 2010 |
Comparison of 0.5 M gadoterate and 1.0 M gadobutrol in peripheral MRA: a prospective, single-center, randomized, crossover, double-blind study.
Topics: Aged; Contrast Media; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heterocyclic Compounds; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Organometallic Compounds; Peripheral Arterial Disease; Reproducibility of Results; Sensitivity and Specificity | 2012 |